Juhaeri Juhaeri | Vice President & Global Head, Epidemiology and Benefit-Risk
Sanofi

Juhaeri is an Epidemiologist with over thirty years of experience in epidemiologic research in academia and in the pharmaceutical industry. He has built and developed various teams at Sanofi, including Epidemiology, Signal Detection, Benefit – Risk Evaluation and Global Safety Sciences, brought and implemented state-of-the art methods and approaches in epidemiology, and led successful epidemiology programs leading to products’ approval and maintenance. He has led different working groups in various public-private collaborations between pharmaceutical industry, academia, and regulatory agencies. He was a member of the Editorial Committee of the CIOMS Working Group XIII on “Real-World Data and Real-World Evidence in Regulatory Decision Making,” and led the development of the “Real – World Data Sources” chapter. CIOMS WG XIII report was published in June this year. Currently, he is the industry co-lead of the European Innovative Health Initiative Real-World Evidence project to generate, pilot-test, and disseminate evidence-based guidance and tools for the use of RWE to inform the development and evaluation of medicines, medical devices, and drug-device combinations. He is a prolific author with extensive publications and presentations at various international conferences.